Science Daily

1. Male bonobos use hidden clues to boost mating success

   Male bonobos have an impressive ability to detect when females are most fertile, even though the usual visual cues are unreliable. Researchers tracking wild bonobos in the Congo discovered that males skillfully interpret a mix of swelling timing and a female’s reproductive history to pinpoint the optimal moment for mating. By blending these clues, they overcome nature’s misleading signals and maximize their chances of fathering offspring.

2. Scientists finally uncovered why the Indus Valley Civilization collapsed

   A series of century-scale droughts may have quietly reshaped one of the world’s earliest urban civilizations. New climate reconstructions show that the Indus Valley Civilization endured repeated long dry periods that gradually pushed its people toward the Indus River as rainfall diminished. These environmental stresses coincided with shrinking cities, shifting settlements, and eventually widespread deurbanization. Rather than a dramatic collapse, the civilization appears to have faded slowly under relentless climate pressure.

3. Harvard gut discovery could change how we treat obesity and diabetes

   Scientists found that certain molecules made by gut bacteria travel to the liver and help control how the body uses energy. These molecules change depending on diet, genetics, and shifts in the microbiome. Some even improved insulin response in liver cells when tested in the lab. The findings could open the door to new ways of preventing or managing obesity and diabetes.

4. The brain switch that could rewrite how we treat mental illness

   Scientists exploring how the brain responds to stress discovered molecular changes that can influence behavior long after an experience ends. They also identified natural resilience systems that help protect certain individuals from harm. These findings are opening the door to treatments that focus on building strength, not just correcting problems. The work is also fueling a broader effort to keep science open, independent, and accessible.

5. Ozempic may offer a surprising bonus benefit for brain health

   A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be less likely to develop epilepsy than those taking DPP-4 inhibitors. Semaglutide showed the strongest connection to lowered risk. Researchers caution that the findings show an association, not proof of cause and effect. More rigorous long-term studies are needed to understand the link.